| NCT ID | NCT05730348 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Eating Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-09-11 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2023-09-11 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to assess mealtime anxiety in patients with eating disorders receiving treatment at an in-patient unit. Anxiety wil be assessed using ecological momentary assessment (EMA). The main research question is: • Does post meal activity reduce anxiety in patients with eating disorders? Study participation will last for two weeks. Participants will be reporting current levels of anxiety/distress on an EMA mobile app during treatment as usual. During one of the two study participation weeks, the participants will perform post mealtime activity.
Eligibility Criteria
Inclusion Criteria: * All patients admitted to the Regional Department for Eating Disorders adult in-patient unit (\>16 years old) will be invited to participate. Exclusion Criteria: * Patients who receive tube feeding for all meals during the study period will be excluded.
Contact & Investigator
Kristin Stedal, PhD
PRINCIPAL INVESTIGATOR
Oslo University Hospital
Frequently Asked Questions
Who can join the NCT05730348 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05730348 currently recruiting?
Yes, NCT05730348 is actively recruiting participants. Contact the research team at krsted@ous-hf.no for enrollment information.
Where is the NCT05730348 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT05730348 clinical trial?
NCT05730348 is sponsored by Oslo University Hospital. The principal investigator is Kristin Stedal, PhD at Oslo University Hospital. The trial plans to enroll 40 participants.